Skip to main content
Caplight Logo









KÄÄPÄ Biotech

KÄÄPÄ Biotech

Private
KarjalohjaHealthcare & Life Scienceshttps://www.kaapabiotech.com/

Last Round

VC Round

Nov 13, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

KÄÄPÄ Biotech is a biotechnology company that specializes in the research, cultivation, and production of functional mushroom extracts for the nutraceutical and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medicinal mushroomsfunctional mushroomsmushroom extractsmycologynutraceutical ingredientscontract manufacturingmushroom myceliumultrasonic extractionNordReleaseadaptogenssuperfood ingredientsprivate label supplementsbiotech supply chainnootropicsforest-based cultivation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KÄÄPÄ Biotech Comparables

Compare KÄÄPÄ Biotech with similar companies based on industry and business-model similarity.

KÄÄPÄ Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nammex
86%
Sempera Organics Inc.
84%
Aloha Medicinals
81%

KÄÄPÄ Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 13, 2025
VC RoundApr 15, 2025

Key People

Founding team and executive leadership

Eric Puro

CEO

Executive Team

Terja Koskenoja

COO Chief Operating Officer Scale-up Growth Production & Business Optimization

Executive Team

Vesa Tiitinen

Group Chief Financial Officer And M&A Leader, Board Member

Executive Team

KÄÄPÄ Biotech Investors

Notable investors and investment history

KÄÄPÄ Biotech investors
InvestorRounds
ZintinusVC Round
PeakBridgeVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 126% MoM.

  • Apr 5, 2026

    Grew 22% QoQ, from 23 to 28 employees.

KÄÄPÄ Biotech Filings

Explore SEC and related filing metadata, where available.

KÄÄPÄ Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KÄÄPÄ Biotech's valuation, stock price, and market status.

Is KÄÄPÄ Biotech a public or private company?

KÄÄPÄ Biotech is a private company.

What is the current stock price of KÄÄPÄ Biotech?

KÄÄPÄ Biotech is a private company with no public stock price. Caplight tracks KÄÄPÄ Biotech's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is KÄÄPÄ Biotech worth (valuation)?

Valuation information for KÄÄPÄ Biotech is not publicly available.

Can I buy KÄÄPÄ Biotech stock?

KÄÄPÄ Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KÄÄPÄ Biotech's last funding round?

KÄÄPÄ Biotech's most recent funding round was VC Round on November 13, 2025.

Who are the main investors in KÄÄPÄ Biotech?

Key investors in KÄÄPÄ Biotech include Zintinus, PeakBridge.

Will KÄÄPÄ Biotech IPO soon?

No public IPO plans have been announced for KÄÄPÄ Biotech.

How can I track KÄÄPÄ Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KÄÄPÄ Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKarjalohja
Employee Range35
Year Founded2018
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?